PE anti-mouse IL-10 Antibody
- 产品名称：
- PE anti-mouse IL-10 Antibody
- 产品类别：
- 抗体
- 产品编号：
- 505007
- 产品应用：
- 505007
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- E. coli-expressed, recombinant mouse IL-10
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
ICFC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by intracellular immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application Notes
ELISA or ELISPOT Detection1,9,11: The biotinylated JES5-16E3 antibody is useful as a detection antibody for a sandwich ELISA or ELISPOT assay, when used in conjunction with purified JES5-2A5 antibody (Cat. Nos. 504902 & 504904) as the capture antibody.
ELISA Capture: The purified JES5-16E3 antibody is useful as the capture antibody in a sandwich ELISA when used in conjunction with the biotinylated JES5-2A5 antibody (Cat. No. 505003) as the detection antibody and recombinant mouse IL-10 (Cat. No. 575809) as the standard.
Neutralization14: The Ultra-LEAF? purified JES5-16E3 antibody can neutralize the bioactivity of natural or recombinant IL-10.
Flow Cytometry3: The fluorochrome-labeled JES5-16E3 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IL-10-producing cells within mixed cell populations.
Additional reported applications (for relevant formats) include: immunohistochemistry3.
- Application References
(PubMed link indicates BioLegend citation) -
- Simkin G, et al. 2000. J. Immunol. 164:2457.
- Kitagaki K, et al. 2002. Clin. Diagn. Lab Immunol. 9:1260.
- Khanna A, et al. 2000. J. Immunol. 164:1346.
- Sander B, et al. 1993. J. Immunol. Methods 166:201.
- Litton M, et al. 1994. J. Immunol. Methods 175:47.
- Andersson U, et al. 1999. Detection and qunatification of gene expression. New York:Springer-Verlag.
- Finkelman F, et al. 2003. Curr. Prot. Immunol. John Wiley & Sons New York. Unit 6.28.
- Wang W, et al. 2004. FASEB J. 18:1043.
- Brummel R and Lenert P. 2005. J. Immunol. 174:2429.
- Lawson BR, et al. 2007. J. Immunol. 178:5366.
- Xu G, et al. 2007. J. Immunol. 179:5358. PubMed
- Brummel R, et al. 2005. J. Immunol.174:2429. PubMed
- Kang YJ, et al. 2007. Stem Cells 25:1814. PubMed
- Seo N, et al. 2001. Immunology. 103:449. (Neut)
- Product Citations
-
- Bergot AS, et al. 2020. J Immunol. 204:1787. PubMed
- Fan L, et al. 2020. J Immunol Res. 2020:3032425. PubMed
- Joly M, et al. 2014. J Immunol. 193:3947. PubMed
- Soon MSF, et al. 2020. Nat Immunol. 1.984027778. PubMed
- Jayachandran R, et al. 2019. Immunity. 50:152. PubMed
- Kawano H, et al. 2016. Int Immunol. 28: 489 - 501. PubMed
- Wei H, et al. 2021. Malar J. 20:89. PubMed
- Hewitson JP, et al. 2020. J Immunol. 204:2949. PubMed
- Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
- Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
- Delacher M, et al. 2021. Immunity. 54(4):702-720.e17. PubMed
- Pina A, et al. 2013. Infect Immun . 81:1064. PubMed
- Piper CJM, et al. 2020. Cell Reports. 29(7):1878-1892.e7.. PubMed
- Lu Y, et al. 2019. Int J Mol Med. 43:2398. PubMed
- Wang Y, et al. 2016. Sci Rep. 6:31881. PubMed
- Tritama E, et al. 2018. Hum Vaccin Immunother. 14:1524. PubMed
- An J, et al. 2022. iScience. 25:103570. PubMed
- Singh K, et al. 2015. Sci Rep. 14:7767. PubMed
- Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
- Habib S, et al. 2018. Infect Immun. 86:e00019. PubMed
- Zhang Q, et al. 2022. Nat Commun. 13:2406. PubMed
- Andersen L, et al. 2020. Cell Reports. 29(13):4447-4459.e6.. PubMed
- Thomas AM, et al. 2020. Journal of Cellular Physiology. 235(6):5120-5129.. PubMed
- Sendler M, et al. 2020. Gastroenterology. 158:253. PubMed
- Gomez S, et al. 2022. J Immunother Cancer. 10:. PubMed
- B?hm L, et al. 2015. J Immunol. 194:887. PubMed
- Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
- Wu B, et al. 2021. Immunity. 54(2):308-323.e6. PubMed
- Itoga M, et al. 2015. PLoS One. 10: e0123210. PubMed
- Asadi Shahmirzadi A, et al. 2020. Cell Metabolism. 32(3):447-456.e6. PubMed
- Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
- Xu W, et al. 2021. Immunity. 54(3):526-541.e7. PubMed
- Prosser A, et al. 2021. STAR Protoc. 2:100810. PubMed
- Imbratta C, et al. 2019. Sci Rep. 9:6135. PubMed
- Wang N, et al. 2020. Front Immunol. 1.765972222. PubMed
- Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed
- Matei DE, et al. 2021. Med (N Y). 2:864. PubMed
- RRID
- AB_315361 (BioLegend Cat. No. 505007) AB_315362 (BioLegend Cat. No. 505008)
- Structure
- Acid-labile cytokine, dimer, 17-21 kD (Mammalian)
- Cell Sources
- Activated CD8+ T cells, Th0, Th2 subset of CD4+ T cells, Ly-1+ B cells, monocytes, macrophages, keratinocytes
- Cell Targets
- T cells, B cells, mast cells, macrophages
- Receptors
- IL-10R (CDw210)
- Cell Type
- Tregs
- Biology Area
- Immunology
- Molecular Family
- Cytokines/Chemokines
- Antigen References
-
1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. de Waal-Malefy R, et al. 1992. Curr. Opin. Immunol. 4:314.
3. Howard M, et al. 1992. Immunol. Today 13:198.
4. Quesniaux V. 1992. Res. Immunol. 143:385.
5. Norton SK, et al. 2008. J. Immunol. 180:2848.
- Regulation
- Downregulated by IL-4, IL-10
- Gene ID
- 16153 View all products for this Gene ID
- UniProt
- View information about IL-10 on UniProt.org
